| Cas No.: | 219685-50-4 |
| pH value: | Corresponds to reference standard: PASS |
| Non-reduced CE-SDS: | 98.5% |
| SEC-HPLC: | 99.7% |
| Isoelectric Point: | Corresponds to reference standard:PASS |
| Bacterial Endotoxins Test: | <1 EU/ml |
| Exogenous Residual DNA: | <1 pg/mg |
| Residual protein A: | <1 ng/mg |
| Biological Activity: | Compared with standard, the range of biological activity is 110% |
| Osmolality: | Corresponds to reference standard: PASS |
| Peptide mapping: | Corresponds to reference standard: PASS |
| N-terminal sequence: | Corresponds to reference standard:PASS |
| Description: | Eculizumab is a long-acting humanized monoclonal antibody targeted against complement C5 and it is used to treat a number of autoimmune conditions. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
